Thar Technologies announced the acquisition of Berger SFC® division of Mettler-Toledo. The combination of the top two supercritical fluid technology companies shall enable the advancement of new technologies and applications, and expand capabilities in the support and service of customers in pharmaceutical drug discovery and development globally.
"We are pleased that we have completed this acquisition." says Thar CEO, Dr. Lalit Chordia. "Berger SFC® brings an excellent reputation and deep experience in the development of Supercritical Fluid Chromatography, and compliments Thar's SFC technologies. We are excited about the future advancement to broaden the scope of SFC technology as a result of this acquisition."
"We strongly believe that the SFC market represents an exciting opportunity. The combination of Berger SFC® and Thar Instruments will result in a fully integrated SFC instrumentation company that will have the necessary critical mass to further penetrate the rapidly developing analysis and purification market, while providing competent support and service to customers around the world.
SFC is at least three to five times faster than HPLC. The high resolution of SFC makes it ideal for the separation and purification of difficult chemical samples, such as chiral enantiomers and natural products. SFC is generally known as normal phase chromatography, thereby offering a complimentary selectivity to HPLC but much greener because it reduces solvent usage by an average of 80%.